XML 98 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock-based compensation
12 Months Ended
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-based compensation
Stock-based compensation

We have stock options outstanding to participants under long-term incentive plans. We also have assumed stock options that were granted by companies that we later acquired. Unless the options are acquisition-related replacement options, the option price per share may not be less than 100 percent of the fair market value of our common stock on the date of the grant. Substantially all the options have a 10-year term and vest ratably over four years. Our options generally continue to vest after the option recipient retires.

We also have RSUs outstanding under long-term incentive plans. Each RSU represents the right to receive one share of TI common stock on the vesting date, which is generally four years after the date of grant. Upon vesting, the shares are issued without payment by the grantee. Beginning with 2013 grants, RSUs generally continue to vest after the recipient retires. Holders of most RSUs receive an annual cash payment equivalent to the dividends paid on our common stock.

We have options and RSUs outstanding to non-employee directors under director compensation plans. The plans generally provide for annual grants of stock options and RSUs, a one-time grant of RSUs to each new non-employee director and the issuance of TI common stock upon the distribution of stock units credited to deferred compensation accounts established for such directors.

We also have an employee stock purchase plan under which options are offered to all eligible employees in amounts based on a percentage of the employee’s compensation, subject to a cap. Under the plan, the option price per share is 85 percent of the fair market value on the exercise date, and options have a three-month term.

Total stock-based compensation expense recognized was as follows:
 
 
For Years Ended December 31,
 
 
2014
 
2013
 
2012
Stock-based compensation expense recognized in:
 
 
 
 
 
 
COR
 
$
48

 
$
49

 
$
48

R&D
 
62

 
67

 
71

SG&A
 
156

 
160

 
127

Acquisition charges
 
11

 
11

 
17

Total
 
$
277

 
$
287

 
$
263



These amounts include expenses related to non-qualified stock options, RSUs and stock options offered under our employee stock purchase plan and are net of expected forfeitures.

We issue awards of non-qualified stock options with graded vesting provisions (e.g., 25 percent per year for four years). Generally, we recognize the related compensation expense on a straight-line basis over the minimum service period required for vesting of the award, adjusting for expected forfeiture activity. Awards issued to employees who are retirement eligible or nearing retirement eligibility are expensed on an accelerated basis.

Our RSUs generally vest four years after the date of grant. We recognize the related compensation expense on a straight-line basis over the vesting period, adjusting for expected forfeiture activity. Beginning with 2013 grants, RSUs issued to employees who are retirement eligible or nearing retirement eligibility are expensed on an accelerated basis.

Fair-value methods and assumptions

We account for all awards granted under our various stock-based compensation plans at fair value. We estimate the fair values for non-qualified stock options using the Black-Scholes-Merton option-pricing model with the following weighted average assumptions.
 
 
For Years Ended December 31,
 
 
2014
 
2013
 
2012
Weighted average grant date fair value, per share
 
$
8.13

 
$
6.78

 
$
8.31

Weighted average assumptions used:
 
 
 
 

 
 

Expected volatility
 
22
%
 
26
%
 
30
%
Expected lives (in years)
 
7.3

 
7.4

 
7.1

Risk-free interest rates
 
2.45
%
 
1.43
%
 
1.40
%
Expected dividend yields
 
2.72
%
 
2.56
%
 
2.10
%


We determine expected volatility on all options granted using available implied volatility rates. We believe that market-based measures of implied volatility are currently the best available indicators of the expected volatility used in these estimates.

We determine expected lives of options based on the historical option exercise experience of our optionees using a rolling 10-year average. We believe the historical experience method is the best estimate of future exercise patterns currently available.

Risk-free interest rates are determined using the implied yield currently available for zero-coupon U.S. government issues with a remaining term equal to the expected life of the options.

Expected dividend yields are based on the annualized approved quarterly dividend rate and the current market price of our common stock at the time of grant. No assumption for a future dividend rate change is included unless there is an approved plan to change the dividend in the near term.

The fair value per share of RSUs is determined based on the closing price of our common stock on the date of grant.

Our employee stock purchase plan is a discount-purchase plan and consequently the Black-Scholes-Merton option-pricing model is not used to determine the fair value per share of these awards. The fair value per share under this plan equals the amount of the discount.

Long-term incentive and director compensation plans

Stock option and RSU transactions under our long-term incentive and director compensation plans during 2014 were as follows:
 
 
Stock Options
 
RSUs
 
 
Shares
 
Weighted Average
Exercise Price
per Share
 
Shares
 
Weighted Average
Grant Date Fair
Value per Share
Outstanding grants, December 31, 2013
 
64,930,540

 
$
28.98

 
20,892,022

 
$
29.94

Granted
 
14,053,185

 
44.11

 
3,184,237

 
44.71

Vested RSUs
 

 

 
(5,609,627
)
 
23.68

Forfeited and expired
 
(1,832,897
)
 
36.54

 
(1,162,817
)
 
33.22

Exercised
 
(19,503,382
)
 
27.75

 

 

Outstanding grants, December 31, 2014
 
57,647,446

 
32.84

 
17,303,815

 
34.47



The weighted average grant date fair value of RSUs granted during the years 2014, 2013 and 2012 was $44.71, $33.70 and $31.60 per share, respectively. For the years ended December 31, 2014, 2013 and 2012, the total grant date fair value of shares vested from RSU grants was $133 million, $98 million and $120 million, respectively.

Summarized information about stock options outstanding at December 31, 2014, is as follows:
 
 
 
Stock Options Outstanding
 
Options Exercisable
Range of
Exercise Price
 
Number
Outstanding
(Shares)
 
Weighted Average
Remaining Contractual
Life (Years)
 
Weighted Average
Exercise Price
per Share
 
Number
Exercisable
(Shares)
 
Weighted Average
Exercise Price
per Share
$
14.47 to 20.00
 
4,061,577

 
4.0
 
$
14.98

 
4,061,577

 
$
14.98

 
20.01 to 30.00
 
11,270,125

 
3.7
 
25.47

 
11,250,200

 
25.46

 
30.01 to 40.00
 
28,910,636

 
6.5
 
33.00

 
12,288,339

 
33.14

 
40.01 to 50.00
 
13,399,020

 
9.1
 
44.10

 
1,750

 
42.66

 
50.01 to 55.41
 
6,088

 
9.9
 
55.41

 

 

 
14.47 to 55.41
 
57,647,446

 
6.4
 
32.84

 
27,601,866

 
27.34



During the years ended December 31, 2014, 2013 and 2012, the aggregate intrinsic value (i.e., the difference in the closing market price on the date of exercise and the exercise price paid by the optionee) of options exercised was $367 million, $427 million and $244 million, respectively.

Summarized information as of December 31, 2014, about outstanding stock options that are vested and expected to vest, as well as stock options that are currently exercisable, is as follows:
 
 
Outstanding Stock Options
(Fully Vested and Expected to Vest) (a)
 
Options
Exercisable
Number of outstanding (shares)
 
56,328,323

 
27,601,866

Weighted average remaining contractual life (in years)
 
6.3

 
4.4

Weighted average exercise price per share
 
$
32.69

 
$
27.34

Intrinsic value (millions of dollars)
 
$
1,170

 
$
721


(a) Includes effects of expected forfeitures of approximately 1 million shares. Excluding the effects of expected forfeitures, the aggregate intrinsic value of stock options outstanding was $1,189 million.

As of December 31, 2014, the total future compensation cost related to equity awards not yet recognized in the Consolidated Statements of Income was $308 million, consisting of $113 million related to unvested stock options and $195 million related to unvested RSUs. The $308 million is expected to be recognized as follows: $168 million in 2015, $91 million in 2016, $44 million in 2017 and $5 million in 2018.

Director deferred compensation

Directors who retire or resign from the board may receive stock distributions for compensation they elected to defer. For these stock distributions, we issued treasury shares. Director deferred stock activity during 2014 was as follows:
 
 
Director Deferred Stock (Shares)
Outstanding, December 31, 2013
 
129,264

New shares deferred
 
13,636

Issued
 
(7,178
)
Outstanding, December 31, 2014
 
135,722


Employee stock purchase plan

Options outstanding under the employee stock purchase plan at December 31, 2014, had an exercise price equal to 85 percent of the fair market value of TI common stock on the date of automatic exercise. The automatic exercise occurred on January 2, 2015, resulting in an exercise price of $45.46 per share. Of the total outstanding options, none were exercisable at year-end 2014.

Employee stock purchase plan transactions during 2014 were as follows:
 
 
Employee Stock
Purchase Plan
(Shares)
 
Exercise Price
Outstanding grants, December 31, 2013
 
485,408

 
$
36.64

Granted
 
1,673,479

 
41.60

Exercised
 
(1,784,184
)
 
39.44

Outstanding grants, December 31, 2014
 
374,703

 
45.46



The weighted average grant date fair value of options granted under the employee stock purchase plans during the years 2014, 2013 and 2012 was $7.34, $5.71 and $4.52 per share, respectively. During the years ended December 31, 2014, 2013 and 2012, the total intrinsic value of options exercised under these plans was $12 million, $13 million and $13 million, respectively.

Effect on shares outstanding and treasury shares
Treasury shares were acquired in connection with the board-authorized stock repurchase program. As of December 31, 2014, $3.17 billion of stock repurchase authorizations remain, and no expiration date has been specified.

Our current practice is to issue shares of common stock from treasury shares upon exercise of stock options, distribution of director deferred compensation and vesting of RSUs. The table below reflects the changes in our treasury shares:

 
 
Stock Options
 
RSUs
 
Treasury Shares
Balance, December 31, 2011
 
 
 
 
 
601,131,631

Repurchases
 
 
 
 
 
59,757,780

Shares used for:
 
 
 
 
 
 
Stock options/RSUs
 
(22,409,816
)
 
(4,182,928
)
 
 
Previously unissued common shares (a)
 
180,955

 
4,593

 
 
Stock applied to taxes
 

 
990,845

 
 
ESPP
 
(2,829,498
)
 

 
 
Director deferred stock
 

 

 
(6,592
)
Total issued
 
(25,058,359
)
 
(3,187,490
)
 
(28,245,849
)
Balance, December 31, 2012
 
 
 
 
 
632,636,970

 
 
 
 
 
 
 
Repurchases
 
 
 
 
 
77,564,013

Shares used for:
 
 
 
 
 
 
Stock options/RSUs
 
(45,507,711
)
 
(5,741,981
)
 
 
Stock applied to taxes
 

 
1,461,422

 
 
ESPP
 
(2,386,834
)
 

 
 
Director deferred stock
 

 

 
(12,909
)
Total issued
 
(47,894,545
)
 
(4,280,559
)
 
(52,175,104
)
Balance, December 31, 2013
 
 
 
 
 
658,012,970

 
 
 
 
 
 
 
Repurchases
 
 
 
 
 
61,665,209

Shares used for:
 
 
 
 
 
 
Stock options/RSUs
 
(19,503,382
)
 
(5,609,627
)
 
 
Stock applied to exercises or taxes
 
6,618

 
1,408,701

 
 
ESPP
 
(1,784,184
)
 

 
 
Director deferred stock
 

 

 
(7,178
)
Total issued
 
(21,280,948
)
 
(4,200,926
)
 
(25,481,874
)
Balance, December 31, 2014
 
 
 
 
 
694,189,127


(a) Beginning in 2013, only treasury shares were issued.


Shares available for future grants and reserved for issuance are summarized below:
 
 
December 31, 2014
Shares
 
Long-Term Incentive
and Director
Compensation Plans
 
Employee Stock
Purchase Plan
 
Total
Reserved for issuance (a)
 
121,127,656

 
39,565,038

 
160,692,694

Shares to be issued upon exercise of outstanding options and RSUs (a)
 
(75,086,983
)
 
(374,703
)
 
(75,461,686
)
Available for future grants
 
46,040,673

 
39,190,335

 
85,231,008



(a) Includes 135,722 shares credited to directors’ deferred stock accounts that settle in shares of TI common stock. These shares are not included as grants outstanding at December 31, 2014.

The effects on cash flows were as follows:

 
 
For Years Ended December 31,
 
 
2014
 
2013
 
2012
Proceeds from common stock transactions
 
$
616

 
$
1,314

 
$
523

Tax benefit realized from stock options exercised
 
218

 
227

 
133